Mariner’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Mariner’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,195,000	Closed	-$252K	–	3052
2023 Q2	$252K	Buy	+1,195,000	New	+$208K	﹤0.01%	2262
2023 Q1	–	Sell	-1,210,990	Closed	-$672K	–	2909
2022 Q4	$672K	Buy	+1,210,990	New	+$1.03M	﹤0.01%	1470
2017 Q1	–	Sell	-10,000	Closed	-$14K	–	612
2016 Q4	$14K	Buy	+10,000	New	+$13.1K	﹤0.01%	566

Other funds holding INFI

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Mariner's INFI Position: Q3 2023 in Review

Mariner sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 1,195,000 shares — an estimated $252K sold.

Mariner first reported a position in INFI in Q4 2016 and held it in 3 quarters. The position peaked at $672K in Q4 2022. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

Mariner reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Mariner sold 1,195,000 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $252K.
Mariner first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2016 and held it in 3 quarters.
Mariner's Infinity Pharmaceuticals, Inc. position peaked at $672K in Q4 2022.
3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Mariner's 13F filing for Q3 2023, filed 13 Nov 2023.